External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma
Preoperative plasma CSF1 was validated as a novel, well-calibrated predictor of poor survival in resectable iCCA, which could assist the preoperative risk assessment. Low plasma TRAIL was associated with early recurrence.
Authors
- Helena Taflin (ORCID: https://orcid.org/0000-0002-8795-5250)
- Niklas K. Björkström (ORCID: https://orcid.org/0000-0002-0967-076X)
- Martin Cornillet (ORCID: https://orcid.org/0000-0001-7981-0927)
- Ernesto Sparrelid (ORCID: https://orcid.org/0000-0003-0259-8328)
- Hannes Jansson (ORCID: https://orcid.org/0000-0002-1833-854X)
- Ghada Nouaïria (ORCID: https://orcid.org/0000-0003-0081-7347)
- Hanna Jacobsson
- A. Akiki
Institutions
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1016/j.ejso.2025.110123
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Royal Swedish Academy of Sciences
- Svenska Läkaresällskapet
- Science for Life Laboratory
- Bengt Ihres Foundation